Patents by Inventor Susan Catalano

Susan Catalano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR TREATING DRY AGE-RELATED MACULAR DEGENERATION (AMD)
    Publication number: 20240009168
    Abstract: The present disclosure relates to methods of treating dry age-related macular degeneration (dry AMD), comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein.
    Type: Application
    Filed: December 10, 2021
    Publication date: January 11, 2024
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Anthony CAGGIANO, Susan CATALANO, Mary HAMBY, Nicholas IZZO, Gary LOOK, Gilbert RISHTON
  • METHOD OF DECREASING AMYLOID BETA MONOMER LEVELS IN PATIENTS WITH COGNITIVE DECLINE
    Publication number: 20230098944
    Abstract: The present disclosure relates to methods of decreasing amyloid ? monomers and methods of treating cognitive decline in a subject, wherein the treatment results in an increase in amyloid ? oligomers and a reduction in cognitive decline. The present disclosure relates to treating cognitive decline, wherein target engagement can be measured in the clinic after treating.
    Type: Application
    Filed: February 12, 2021
    Publication date: March 30, 2023
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Susan CATALANO, Nicholas IZZO
  • Inhibitors of cognitive decline
    Patent number: 9815770
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: November 14, 2017
    Assignee: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • System and method for high-content oncology assay
    Patent number: 9702865
    Abstract: The present invention provides an apparatus, system, method and computer program and computer program product for analyzing cellular samples. One embodiment of the apparatus and method provides a multiparameter assay that provides information with respect to cell proliferation, cell cycling and cell death. The multiparameter assay is particularly useful for assessing and screening candidate compounds for anti-cancer utility.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: July 11, 2017
    Assignee: RIGEL PHARMACEUTICALS, INC.
    Inventors: Susan Catalano, John McLaughlin
  • 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
    Patent number: 9598432
    Abstract: The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
    Type: Grant
    Filed: July 7, 2014
    Date of Patent: March 21, 2017
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ankush Argade, Rajinder Singh, Hui Li, David Carroll, Susan Catalano
  • ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE
    Publication number: 20170049723
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods for treatment, inhibition, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: October 11, 2016
    Publication date: February 23, 2017
    Inventors: Gilbert M. RISHTON, Susan CATALANO
  • INHIBITORS OF COGNITIVE DECLINE
    Publication number: 20160355458
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: June 13, 2016
    Publication date: December 8, 2016
    Inventors: Gilbert M. Rishton, Susan Catalano
  • Isolated compounds from turmeric oil and methods of use
    Patent number: 9499462
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods for treatment, inhibition, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: November 22, 2016
    Assignee: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • Inhibitors of cognitive decline
    Patent number: 9365491
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Grant
    Filed: June 2, 2014
    Date of Patent: June 14, 2016
    Assignee: COGNITION THERAPEUTICS, INC.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • INHIBITORS OF COGNITIVE DECLINE
    Publication number: 20160137588
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: October 16, 2015
    Publication date: May 19, 2016
    Inventors: Gilbert M. Rishton, Susan Catalano
  • Inhibitors of cognitive decline
    Patent number: 9192585
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: November 24, 2015
    Assignee: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • COMPOSITIONS AND METHOD FOR DETERMINING THE EFFICACY OF AMYLOIDOSIS TREATMENTS
    Publication number: 20150160228
    Abstract: Embodiments described herein are directed to a composition for preparing amyloid ? fibrils or oligomers in vitro, testing compounds with putative amyloid ? activity, amyloid ? fibrils and/or oligomers prepared using such compositions, and proteins identified as being associated with amyloid ? fibrils and oligomers in the composition.
    Type: Application
    Filed: February 7, 2011
    Publication date: June 11, 2015
    Inventor: Susan CATALANO
  • 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents
    Publication number: 20150011002
    Abstract: The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
    Type: Application
    Filed: July 7, 2014
    Publication date: January 8, 2015
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Ankush Argade, Rajinder Singh, Hui Li, David Carroll, Susan Catalano
  • INHIBITORS OF COGNITIVE DECLINE
    Publication number: 20140371324
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: June 2, 2014
    Publication date: December 18, 2014
    Applicant: COGNITION THERAPEUTICS, INC.
    Inventors: Gilbert M. RISHTON, Susan CATALANO
  • 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
    Patent number: 8809341
    Abstract: The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: August 19, 2014
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ankush Argade, Rajinder Singh, Hui Li, David Carroll, Susan Catalano
  • Inhibitors of cognitive decline
    Patent number: 8765816
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods of treating, inhibiting, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Grant
    Filed: April 6, 2010
    Date of Patent: July 1, 2014
    Assignee: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • ISOLATED COMPOUNDS FROM TURMERIC OIL AND METHODS OF USE
    Publication number: 20140080916
    Abstract: Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimer's disease are provided. Methods for treatment, inhibition, and/or abatement of cognitive decline and/or Alzheimer's disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.
    Type: Application
    Filed: February 1, 2012
    Publication date: March 20, 2014
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Gilbert M. Rishton, Susan Catalano
  • System and Method for High-Content Oncology Assay
    Publication number: 20130280701
    Abstract: The present invention provides an apparatus, system, method and computer program and computer program product for analyzing cellular samples. One embodiment of the apparatus and method provides a multiparameter assay that provides information with respect to cell proliferation, cell cycling and cell death. The multiparameter assay is particularly useful for assessing and screening candidate compounds for anti-cancer utility.
    Type: Application
    Filed: March 1, 2013
    Publication date: October 24, 2013
    Inventors: SUSAN CATALANO, JOHN McLAUGHLIN
  • System and method for high-content oncology assay
    Patent number: 8412504
    Abstract: The present invention provides an apparatus, system, method and computer program and computer program product for analyzing cellular samples. One embodiment of the apparatus and method provides a multiparameter assay that provides information with respect to cell proliferation, cell cycling and cell death. The multiparameter assay is particularly useful for assessing and screening candidate compounds for anti-cancer utility.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: April 2, 2013
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Susan Catalano, John McLaughlin
  • METHODS OF IDENTIFYING AGENTS EFFECTIVE TO TREAT COGNITIVE DECLINE AND DISEASES ASSOCIATED THEREWITH
    Publication number: 20130071330
    Abstract: Embodiments described herein are directed to methods of identifying agents effective to treat cognitive decline and diseases associated therewith. Embodiments described herein are also directed to kits for performing methods described herein. Embodiments described are also directed to methods of diagnosis and uses of the same.
    Type: Application
    Filed: February 28, 2011
    Publication date: March 21, 2013
    Inventor: Susan Catalano